Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Indrayani Biotech

526445
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Indrayani Biotech Share price and Fundamental Analysis

View All Details
View All Details
Indrayani Biotech Limited was incorporated in 1992. The Company came out with a public issue in 1994 to part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. Presently, the Company is engaged in manufacture of electric motors, generators, transformers and electricity distribution and control apparatus
Company Incorporation1992
ChairmanN M Ranganathan
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
52.59
PE Ratio
0
Industry P/E
28.55
PEG Ratio
0
ROE
-8.42%
ROCE
-1.13%
ROA
-2.54%
Total Debt (Cr)
137.08
Debt to Equity
1.89
Dividend Yield
0%
EPS
0
Book Value & P/B
15.92 x 0.73
Face Value
10
Outstanding Shares(Cr)
4.55
Current Ratio
5.77
EV to Sales
1.48

Included In

+More

Stock Returns

1 Week-9.41%
1 Month-18.95%
6 Months-44.71%
1 Year-75.73%
3 Years-85.46%
5 Years+31.25%
no_data

No Stocks

Smart Score

1.9
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Jun 25

Promoters : 33.28%

FIIs : 0.00%

DIIs : 3.11%

Public : 63.61%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 24.61% of holding in June 2025 Qtr
DII Shareholding Decreased by 0.55% to 3.11% in June 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Indrayani Biotech Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Indrayani Biotech Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Indrayani Biotech Limited was incorporated in 1992. The Company came out with a public issue in 1994 to part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. Presently, the Company is engaged in manufacture of electric motors, generators, transformers and electricity distribution and control apparatus

Technical agreements have been signed with Floral Max, Malaysia; for rose cultivation; and with B L McKenzie and Associates, New Zealand, for tissue culture. The planting material for strawberries has been acquired from the US. The company has signed a test agreement with the Technology Transfer Offer of the University of California to obtain certified planting material from nurseries in California.

IBL started exporting flowers to Holland and Dubai during 1994-95. Restricted water supply and changes in ecology resulted in a shortfall in achieving its goals.

In 1995-96, the company incurred losses due to reasons beyond the control of the management like insufficient water supply, labour problem and sub-standard infrastructure. To overcome the above problems, the company is considering to shift its green houses to alternate locations.

During the year 2010-11, the Scheme of Arrangement, seeking to reduce the equity share capital of the Company by 88%, conversion of unsecured loan into the equity shares, demerging the entire business into Indrayani Tissue Culture Pvt. Ltd., merging YoGoYo Division of Websource Technologies Ltd., was effective from August 21, 2010. Similarly, the Scheme of Arrangement for Amalgamation of Helios Solutions Limited and A-Diet Express Hospitality Services Limited as a going concern with the Company was made effective from April 1, 2018.

IBL Investments Ltd was incorporated as wholly owned subsidiary company in 2022-23; Dindigul Farm Product Pvt Ltd became subsidiary in 2022-23.

Indrayani Biotech Share Price

Indrayani Biotech share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Indrayani Biotech Market Cap

Market capitalization of Indrayani Biotech indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Indrayani Biotech is valued compared to its competitors.

Indrayani Biotech PE Ratio

Indrayani Biotech PE ratio helps investors understand what is the market value of each stock compared to Indrayani Biotech 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Indrayani Biotech PEG Ratio

The PEG ratio of Indrayani Biotech evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Indrayani Biotech ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Indrayani Biotech generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Indrayani Biotech ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Indrayani Biotech in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Indrayani Biotech Total Debt

Total debt of Indrayani Biotech shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Indrayani Biotech Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Indrayani Biotech compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Indrayani Biotech CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Indrayani Biotech over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Indrayani Biotech Technical Analysis

Technical analysis of Indrayani Biotech helps investors get an insight into when they can enter or exit the stock. Key components of Indrayani Biotech Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Indrayani Biotech shares often struggle to rise above due to selling pressure.

Indrayani Biotech Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Indrayani Biotech ’s financial health and profitability.

Indrayani Biotech Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Indrayani Biotech Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Indrayani Biotech Financials

The financials of Indrayani Biotech provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Indrayani Biotech Profit and Loss Statements

The profit and loss statement of Indrayani Biotech highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Indrayani Biotech .

Indrayani Biotech Balance Sheet

The balance sheet presents a snapshot of Indrayani Biotech ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Indrayani Biotech Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.